HSIC vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

HSIC

58.8
AI Score
VS
HSIC Wins

XRAY

42.7
AI Score

Investment Advisor Scores

HSIC

59score
Recommendation
HOLD

XRAY

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HSIC XRAY Winner
Forward P/E 14.9477 7.2359 XRAY
PEG Ratio 1.7595 0.7238 XRAY
Revenue Growth 4.0% -4.1% HSIC
Earnings Growth 26.2% 15.2% HSIC
Tradestie Score 58.8/100 42.7/100 HSIC
Profit Margin 3.1% -15.0% HSIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HSIC 1M: -0.9% · 3M: -3.7% XRAY 1M: +3.7% · 3M: -18.1%

Current Technical Phase

HSIC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $86.22

XRAY

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -6.9%) with fading momentum, RSI 45

RSI (14): 45.0 · Price: $9.16

Fundamentals Snapshot

Metric HSIC XRAY
Market Cap — —
Forward P/E 14.4 7.3
Trailing P/E 23.6 —
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.0%
EPS 3.65 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, HSIC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.